The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Estradot 25 micrograms/24 hours, transdermal patch



Novartis Ireland LimitedPA0896/010/005

Main Information

Trade NameEstradot 25 micrograms/24 hours, transdermal patch
Active SubstancesEstradiol hemihydrate
Dosage FormTransdermal patch
Licence HolderNovartis Ireland Limited
Licence NumberPA0896/010/005

Group Information

ATC CodeG03CA Natural and semisynthetic estrogens, plain
G03CA03 estradiol

Status

License statusAuthorised
Licence Issued24/05/2005
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back